California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine (CIRM) is a state agency dedicated to accelerating innovative cell and gene therapies. It achieves this by funding groundbreaking research and establishing crucial infrastructure for scientific advancement. CIRM also supports the regenerative medicine ecosystem through educational and training programs, translating discoveries into clinical applications.

CIRM was established in 2004 when California voters approved Proposition 71, creating a public entity to fund stem cell research. The foundational insight provided state-level investment, particularly responding to federal restrictions. Voters reinforced this commitment in 2020 with Proposition 14, further extending the institute's funding for its mission.

The institute primarily serves researchers and patients seeking advanced treatments for debilitating diseases. CIRM's vision is to deliver transformative regenerative medicine therapies, profoundly impacting healthcare for conditions like cancer, diabetes, and genetic disorders. This effort strengthens California's position as a leading biotech innovation hub.